Moonwalk Biosciences Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$70M
- Investors
-
8
Moonwalk Biosciences General Information
Description
Operator of a genomic medicine company intended to develop precision epigenetic medicines. The company offers profiling and engineering technologies that analyze the epigenome using artificial intelligence-based prediction, enabling healthcare providers to develop therapies that reprogram cells toward a healthy state.
Contact Information
Website
www.moonwalk.bioCorporate Office
- 2 Tower Place
- 8th Floor
- San Francisco, CA 94080
- United States
Corporate Office
- 2 Tower Place
- 8th Floor
- San Francisco, CA 94080
- United States
Moonwalk Biosciences Timeline
Moonwalk Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 08-Sep-2026 | $70M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series A) | 04-Jan-2024 | Completed | Startup |
Moonwalk Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | 8,192,575 | $0.000100 | $6.13 | $6.13 | 1x | $6.13 | 22.11% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Moonwalk Biosciences Comparisons
Industry
Financing
Details
Moonwalk Biosciences Competitors (58)
One of Moonwalk Biosciences’s 58 competitors is Alia Therapeutics, a Venture Capital-Backed company based in Pergine Valsugana, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alia Therapeutics | Venture Capital-Backed | Pergine Valsugana, Italy | ||||
| EdiGene | Venture Capital-Backed | Beijing, China | ||||
| PHD Biosciences | Venture Capital-Backed | La Jolla, CA | ||||
| PhoreMost | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| PAQ Therapeutics | Venture Capital-Backed | Cambridge, MA |
Moonwalk Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Moonwalk Biosciences Patents
Moonwalk Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024182440-A2 | Methods and compositions for modifying nucleotide sequences | Inactive | 28-Feb-2023 | ||
| WO-2024182440-A3 | Methods and compositions for modifying nucleotide sequences | Inactive | 28-Feb-2023 | ||
| US-20260110025-A1 | Methods and systems for long-range methylation profiling | Pending | 30-Dec-2022 | ||
| WO-2024145617-A1 | Methods and systems for long-range methylation profiling | Inactive | 30-Dec-2022 | ||
| WO-2024112806-A1 | Generation and use of epigenetic maps for drug discovery | Inactive | 21-Nov-2022 | C12N5/0636 |
Moonwalk Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Moonwalk Biosciences Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eli Lilly and Company Foundation | Limited Partner | Minority | ||
| Gaorong Ventures | Venture Capital | Minority | ||
| Alpha Wave Global | Growth/Expansion | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Future Ventures (San Francisco) | Venture Capital | Minority |
Moonwalk Biosciences FAQs
-
When was Moonwalk Biosciences founded?
Moonwalk Biosciences was founded in 2022.
-
Where is Moonwalk Biosciences headquartered?
Moonwalk Biosciences is headquartered in San Francisco, CA.
-
What is the size of Moonwalk Biosciences?
Moonwalk Biosciences has 21 total employees.
-
What industry is Moonwalk Biosciences in?
Moonwalk Biosciences’s primary industry is Drug Discovery.
-
Is Moonwalk Biosciences a private or public company?
Moonwalk Biosciences is a Private company.
-
What is the current valuation of Moonwalk Biosciences?
The current valuation of Moonwalk Biosciences is .
-
What is Moonwalk Biosciences’s current revenue?
The current revenue for Moonwalk Biosciences is .
-
How much funding has Moonwalk Biosciences raised over time?
Moonwalk Biosciences has raised $127M.
-
Who are Moonwalk Biosciences’s investors?
Eli Lilly and Company Foundation, Gaorong Ventures, Alpha Wave Global, ARCH Venture Partners, and Future Ventures (San Francisco) are 5 of 8 investors who have invested in Moonwalk Biosciences.
-
Who are Moonwalk Biosciences’s competitors?
Alia Therapeutics, EdiGene, PHD Biosciences, PhoreMost, and PAQ Therapeutics are some of the 58 competitors of Moonwalk Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
